Search

Your search keyword '"Agnieszka Latosinska"' showing total 113 results

Search Constraints

Start Over You searched for: Author "Agnieszka Latosinska" Remove constraint Author: "Agnieszka Latosinska"
113 results on '"Agnieszka Latosinska"'

Search Results

1. Urinary peptides provide information about the risk of mortality across a spectrum of diseases and scenarios

2. Small peptide CSF fingerprint of amyotrophic lateral sclerosis.

3. OSTEO18, a novel urinary proteomic signature, associated with osteoporosis in heart transplant recipients

4. Integration of Urinary Peptidome and Fecal Microbiome to Explore Patient Clustering in Chronic Kidney Disease

5. The novel proteomic signature for cardiac allograft vasculopathy

6. Prognosis and Personalized In Silico Prediction of Treatment Efficacy in Cardiovascular and Chronic Kidney Disease: A Proof-of-Concept Study

7. Urine peptidome analysis in cardiorenal syndrome reflects molecular processes

8. The novel urinary proteomic classifier HF1 has similar diagnostic and prognostic utility to BNP in heart failure

9. Bile and urine peptide marker profiles: access keys to molecular pathways and biological processes in cholangiocarcinoma

10. A novel urinary biomarker predicts 1-year mortality after discharge from intensive care

11. The Implant Proteome—The Right Surgical Glue to Fix Titanium Implants In Situ

12. Discovery, validation and sequencing of urinary peptides for diagnosis of liver fibrosis—A multicentre study

13. Plasma proteomic analysis reveals altered protein abundances in cardiovascular disease

14. Molecular Mapping of Urinary Complement Peptides in Kidney Diseases

15. Collagen-Derived Peptides in CKD: A Link to Fibrosis

16. Reproducibility Evaluation of Urinary Peptide Detection Using CE-MS

17. Omics Derived Biomarkers and Novel Drug Targets for Improved Intervention in Advanced Prostate Cancer

18. Molecular Changes in Tissue Proteome during Prostate Cancer Development: Proof-of-Principle Investigation

19. Analytical Performance of ELISA Assays in Urine: One More Bottleneck towards Biomarker Validation and Clinical Implementation.

20. Promise and Implementation of Proteomic Prostate Cancer Biomarkers

21. Comparative Analysis of Label-Free and 8-Plex iTRAQ Approach for Quantitative Tissue Proteomic Analysis.

22. Comparison of Depletion Strategies for the Enrichment of Low-Abundance Proteins in Urine.

23. Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development

24. Uniform Manifold Approximation and Projection-based Assessment of Chronic Kidney Disease Aetiologies based on Urinary Peptidomics

25. Multiple urinary peptides display distinct sex-specific distribution

26. Plasma and Urinary Biomarkers Improve Prediction of Mortality through 1 Year in Intensive Care Patients: An Analysis from FROG-ICU

27. Statistical approaches applicable in managing OMICS data: Urinary proteomics as exemplary case

28. The COV50 classifier predicts frailty and future death, independent from SARS-CoV-2 infection

29. Urinary Proteomic Signature of Mineralocorticoid Receptor Antagonism by Spironolactone: Evidence from the Randomized-Controlled HOMAGE and PRIORITY Trials

32. Increased Collagen Turnover Is a Feature of Fibromuscular Dysplasia and Associated With Hypertrophic Radial Remodeling: A Pilot, Urine Proteomic Study

33. Mass Spectrometry-Based Biomarkers to Detect Prostate Cancer: A Multicentric Study Based on Non-Invasive Urine Collection without Prior Digital Rectal Examination

35. Cardioprotection by selective SGLT-2 inhibitors in a non-diabetic mouse model of myocardial ischemia/reperfusion injury

36. Proteomic Analysis of Prostate Cancer FFPE Samples Reveals Markers of Disease Progression and Aggressiveness

37. Proteomic Biomarkers in the Cardiorenal Syndrome: Toward Deciphering Molecular Pathophysiology

38. The urinary proteomic profile of fibromuscular dysplasia

39. MO379: Collagen-Derived Peptides in CKD: A Link to Fibrosis

40. A model to detect significant prostate cancer integrating urinary peptide and extracellular vesicle RNA data

41. Proteomic characterization of obesity-related nephropathy

42. Bile and urine peptide marker profiles: access keys to molecular pathways and biological processes in cholangiocarcinoma

43. Urinary collagen-derived peptides as sensitive markers for bone resorption and bisphosphonate treatment in kidney transplant patients

44. Reproducibility Evaluation of Urinary Peptide Detection Using CE-MS

45. The novel proteomic signature for the detection of cardiac allograft vasculopathy

46. Comparative study on the cardioprotective effect of selective sodium glucose co-transporter 2 inhibitors in a non-diabetic mouse model of myocardial ischemia/reperfusion injury

47. Urine peptidome analysis in cardiorenal syndrome reflects molecular processes

48. SGLT2-Inhibition reverts urinary peptide changes associated with severe COVID-19: anin-silicoproof-of-principle of proteomics-based drug repurposing

49. Proteome‐based classification of Nonmuscle Invasive Bladder Cancer

50. Molecular mapping of urinary complement peptides in kidney diseases

Catalog

Books, media, physical & digital resources